描述
Mechanism of action or clinical trial results for tapinarof, a novel topical aryl hydrocarbon receptor agonist under investigation for mild-to-moderate psoriasis treatment.
Cite This Figure
![Figure 1: Mechanism of action or clinical trial results for tapinarof, a novel topical aryl hydrocarbon receptor agonist under investigation for mild-to-moderate psoriasis treatment.]() > Source: Sofia Nogueira et al. "Tapinarof for the treatment of psoriasis.." *Dermatologic therapy*, 2022. PMID: [36226669](https://pubmed.ncbi.nlm.nih.gov/36226669/)
<figure> <img src="" alt="Mechanism of action or clinical trial results for tapinarof, a novel topical aryl hydrocarbon receptor agonist under investigation for mild-to-moderate psoriasis treatment." /> <figcaption>Figure 1. Mechanism of action or clinical trial results for tapinarof, a novel topical aryl hydrocarbon receptor agonist under investigation for mild-to-moderate psoriasis treatment.<br> Source: Sofia Nogueira et al. "Tapinarof for the treatment of psoriasis.." <em>Dermatologic therapy</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36226669/">36226669</a></figcaption> </figure>